BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15986138)

  • 1. Protein kinase C in melanoma.
    Oka M; Kikkawa U
    Cancer Metastasis Rev; 2005 Jun; 24(2):287-300. PubMed ID: 15986138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta, -epsilon, and -zeta isozyme levels in proliferating human melanoma cells.
    Krasagakis K; Fimmel S; Genten D; Eberle J; Quas P; Ziegler W; Haller H; Orfanos CE
    Int J Oncol; 2002 Apr; 20(4):865-71. PubMed ID: 11894137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional alterations in protein kinase C beta II expression in melanoma.
    Voris JP; Sitailo LA; Rahn HR; Defnet A; Gerds AT; Sprague R; Yadav V; Caroline Le Poole I; Denning MF
    Pigment Cell Melanoma Res; 2010 Apr; 23(2):216-24. PubMed ID: 20015121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of protein kinase C and cAMP-dependent protein kinase in normal human melanocytes and malignant melanomas.
    Becker D; Beebe SJ; Herlyn M
    Oncogene; 1990 Aug; 5(8):1133-9. PubMed ID: 2392322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of PKC isoforms in human melanocytic cells in situ.
    Oka M; Nishigori C; Kageshita T; Hsu MY; Penmatcha S; Herlyn M
    J Dermatol Sci; 2006 Feb; 41(2):157-61. PubMed ID: 16406501
    [No Abstract]   [Full Text] [Related]  

  • 6. Specifying protein kinase C functions in melanoma.
    Denning MF
    Pigment Cell Melanoma Res; 2012 Jul; 25(4):466-76. PubMed ID: 22578192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage.
    Selzer E; Okamoto I; Lucas T; Kodym R; Pehamberger H; Jansen B
    Melanoma Res; 2002 Jun; 12(3):201-9. PubMed ID: 12140376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin signaling in malignant melanoma.
    Kuphal S; Bauer R; Bosserhoff AK
    Cancer Metastasis Rev; 2005 Jun; 24(2):195-222. PubMed ID: 15986132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting STAT3 affects melanoma on multiple fronts.
    Kortylewski M; Jove R; Yu H
    Cancer Metastasis Rev; 2005 Jun; 24(2):315-27. PubMed ID: 15986140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation of the mitogen-activated protein kinase pathway.
    Cozzi SJ; Parsons PG; Ogbourne SM; Pedley J; Boyle GM
    Cancer Res; 2006 Oct; 66(20):10083-91. PubMed ID: 17047072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
    Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
    Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of DUSP6 phosphatase stimulate tumourigenesis in a molecularly distinct melanoma subtype.
    Li W; Song L; Ritchie AM; Melton DW
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):188-99. PubMed ID: 22171919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?
    Gilhooly EM; Morse-Gaudio M; Bianchi L; Reinhart L; Rose DP; Connolly JM; Reed JA; Albino AP
    Melanoma Res; 2001 Aug; 11(4):355-69. PubMed ID: 11479424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rb/E2F: a two-edged sword in the melanocytic system.
    Halaban R
    Cancer Metastasis Rev; 2005 Jun; 24(2):339-56. PubMed ID: 15986142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cell cycle regulatory proteins in the pathogenesis of melanoma.
    Li W; Sanki A; Karim RZ; Thompson JF; Soon Lee C; Zhuang L; McCarthy SW; Scolyer RA
    Pathology; 2006 Aug; 38(4):287-301. PubMed ID: 16916716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant melanoma--a PO-cell tumor? (author's transl)].
    Schmidt H; Stintz AR
    Arch Geschwulstforsch; 1975; 45(2):146-52. PubMed ID: 812451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of specific protein kinase C subspecies in human melanoma cells.
    Oka M; Ogita K; Ando H; Horikawa T; Hayashibe K; Saito N; Kikkawa U; Ichihashi M
    J Cell Physiol; 1996 Jun; 167(3):406-12. PubMed ID: 8655594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells.
    Fan F; Feng L; He J; Wang X; Jiang X; Zhang Y; Wang Z; Chen Y
    Carcinogenesis; 2008 Jun; 29(6):1157-63. PubMed ID: 18515281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-dependent kinase 2 expression in human melanomas and benign melanocytic skin lesions.
    Kuźbicki L; Aładowicz E; Chwirot BW
    Melanoma Res; 2006 Oct; 16(5):435-44. PubMed ID: 17013093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray analysis of phosphatase gene expression in human melanoma.
    McArdle L; Rafferty MM; Satyamoorthy K; Maelandsmo GM; Dervan PA; Herlyn M; Easty DJ
    Br J Dermatol; 2005 May; 152(5):925-30. PubMed ID: 15888148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.